Home › Encyclopedia › Pentapeptide-18: Uses, Research Status, and Safety Data
Research / Unapproved

Pentapeptide-18: Uses, Research Status, and Safety Data

Molecular formulaC29H39N5O7
Molecular weight569.6 g/mol
Registered trials0
PubChem CID10099522

Regulatory status

Pentapeptide-18 is an unapproved research compound. It does not have an FDA-approved label, and no regulatory agency has cleared it for any medical use in humans.

What pentapeptide-18 is

Pentapeptide-18 is a synthetic peptide with the molecular formula C29H39N5O7 and a molecular weight of about 569.6 g/mol (PubChem CID 10099522). As its name indicates, it is built from a chain of five amino acid residues. No FDA label, approved indication, or established mechanism of action has been published for this compound.

What the evidence shows

Public trial registries list no registered clinical trials for pentapeptide-18. There is currently no clinical trial sample to summarize, and no data describing outcomes, dosing populations, or study phases are available.

FAQ

Is pentapeptide-18 FDA-approved?
No. Pentapeptide-18 is classified as an unapproved research compound. There is no FDA-approved label, brand name, or medical indication associated with it.
What is pentapeptide-18 made of?
It is a synthetic peptide with the chemical formula C29H39N5O7 and a molecular weight of approximately 569.6 g/mol. This chemical identity is catalogued under PubChem CID 10099522.
Are there clinical trials studying pentapeptide-18?
Current public trial registries show no registered clinical trials for this compound. As a result, there is no clinical evidence available describing its effects in humans.
What side effects does pentapeptide-18 cause?
There is no available adverse event data for pentapeptide-18 at this time. Without clinical trials or an approved label, no side effect profile has been established.
What is pentapeptide-18 used for?
Because pentapeptide-18 has no FDA approval or published clinical trial data, no approved or evidence-based use can be described. It remains an unapproved research compound only.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 10099522 ClinicalTrials.gov registry search

Updated 2026-09-19